Kam padedameMūsų mokslasProduktaiRezultatai
PrisijungtiKlaustiPradėtinuo 449 $
Požymis
Abdominal pain
An unpleasant sensation characterized by physical discomfort (such as pricking, throbbing, or aching) and perceived to originate in the abdomen.
Santrauka
- Taip pat vadinama
- Abdominal discomfort, Gastro pain, Gastrointestinal pain, Pain in stomach, Stomach pain, Upset stomach
Abdominal painHP:0002027
Kam padedameMūsų mokslasProduktaiRezultatai
PrisijungtiKlaustiPradėtinuo 449 $
Read the genes linked to Abdominal pain, and the rest of your genome, with one test.
Nuo 449 $Nemokamas pristatymas · Rezultatai per 6–8 savaites
Įsigyti savo Genome Test327 genų susiję su Abdominal pain
Šių genų pakitimai sukelia retas ligas, kuriose pasireiškia Abdominal pain. Dauguma žmonių, turinčių šį požymį, neturi nė vienos iš tų ligų, o šiame sąraše esantis genas nieko nesako apie kieno nors paties genomą.
| Genas | Kaip dažnai pasireiškia | Ligos |
|---|---|---|
| ABCB1ATP binding cassette subfamily B member 1 | Visada | 1 ligoje |
| APRTadenine phosphoribosyltransferase | Visada | 1 ligoje |
| CARD8caspase recruitment domain family member 8 | Visada | 1 ligoje |
| CASKcalcium/calmodulin dependent serine protein kinase | Visada | 1 ligoje |
| CEBPECCAAT enhancer binding protein epsilon | Visada | 1 ligoje |
| FDXRferredoxin reductase | Visada | 1 ligoje |
| G6PDglucose-6-phosphate dehydrogenase | Visada | 1 ligoje |
| GUK1guanylate kinase 1 | Visada | 1 ligoje |
| IRF4interferon regulatory factor 4 | Visada | 2 ligose |
| LYNLYN proto-oncogene, Src family tyrosine kinase | Visada | 1 ligoje |
| NCF4neutrophil cytosolic factor 4 | Visada | 1 ligoje |
| PIGTphosphatidylinositol glycan anchor biosynthesis class T | Visada | 1 ligoje |
| PIGYphosphatidylinositol glycan anchor biosynthesis class Y | Visada | 1 ligoje |
| PIK3CGphosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma | Visada | 1 ligoje |
| PLD4phospholipase D family member 4 | Visada | 1 ligoje |
| PPOXprotoporphyrinogen oxidase | Visada | 2 ligose |
| RAD21RAD21 cohesin complex component | Visada | 1 ligoje |
| RNU6ATACRNA, U6atac small nuclear | Visada | 1 ligoje |
| STK11serine/threonine kinase 11 | Visada | 2 ligose |
| TRU-TCA1-1tRNA-SeC (anticodon TCA) 1-1 | Visada | 1 ligoje |
| ABCD1ATP binding cassette subfamily D member 1 | Labai dažnai (80–99%) | 1 ligoje |
| ALDOBaldolase, fructose-bisphosphate B | Labai dažnai (80–99%) | 2 ligose |
| ATMATM serine/threonine kinase | Labai dažnai (80–99%) | 1 ligoje |
| ATP7AATPase copper transporting alpha | Labai dažnai (80–99%) | 1 ligoje |
| BAZ1Bbromodomain adjacent to zinc finger domain 1B | Labai dažnai (80–99%) | 1 ligoje |
| BMPR1Abone morphogenetic protein receptor type 1A | Labai dažnai (80–99%) | 3 ligose |
| BRCA1BRCA1 DNA repair associated | Labai dažnai (80–99%) | 3 ligose |
| BRCA2BRCA2 DNA repair associated | Labai dažnai (80–99%) | 4 ligose |
| BUD23BUD23 rRNA methyltransferase and ribosome maturation factor | Labai dažnai (80–99%) | 1 ligoje |
| CASRcalcium sensing receptor | Labai dažnai (80–99%) | 2 ligose |
| CD4CD4 molecule | Labai dažnai (80–99%) | 1 ligoje |
| CDKN2Acyclin dependent kinase inhibitor 2A | Labai dažnai (80–99%) | 2 ligose |
| CHEK2checkpoint kinase 2 | Labai dažnai (80–99%) | 1 ligoje |
| CLIP2CAP-Gly domain containing linker protein 2 | Labai dažnai (80–99%) | 1 ligoje |
| CPA1carboxypeptidase A1 | Labai dažnai (80–99%) | 1 ligoje |
| CPOXcoproporphyrinogen oxidase | Labai dažnai (80–99%) | 2 ligose |
| CTNNB1catenin beta 1 | Labai dažnai (80–99%) | 3 ligose |
| CTRCchymotrypsin C | Labai dažnai (80–99%) | 2 ligose |
| DNAJC30DnaJ heat shock protein family (Hsp40) member C30 | Labai dažnai (80–99%) | 1 ligoje |
| ECE1endothelin converting enzyme 1 | Labai dažnai (80–99%) | 1 ligoje |
Rodyti dar 287 genų
| Genas | Kaip dažnai pasireiškia | Ligos |
|---|---|---|
| EDN3endothelin 3 | Labai dažnai (80–99%) | 2 ligose |
| EDNRBendothelin receptor type B | Labai dažnai (80–99%) | 2 ligose |
| EIF4Heukaryotic translation initiation factor 4H | Labai dažnai (80–99%) | 1 ligoje |
| ELNelastin | Labai dažnai (80–99%) | 1 ligoje |
| EPCAMepithelial cell adhesion molecule | Labai dažnai (80–99%) | 1 ligoje |
| ERBB2erb-b2 receptor tyrosine kinase 2 | Labai dažnai (80–99%) | 1 ligoje |
| ERBB3erb-b2 receptor tyrosine kinase 3 | Labai dažnai (80–99%) | 1 ligoje |
| EWSR1EWS RNA binding protein 1 | Labai dažnai (80–99%) | 1 ligoje |
| FKBP6FKBP prolyl isomerase family member 6 (inactive) | Labai dažnai (80–99%) | 1 ligoje |
| FSHRfollicle stimulating hormone receptor | Labai dažnai (80–99%) | 2 ligose |
| GDNFglial cell derived neurotrophic factor | Labai dažnai (80–99%) | 1 ligoje |
| GHSRgrowth hormone secretagogue receptor | Labai dažnai (80–99%) | 1 ligoje |
| GLAgalactosidase alpha | Labai dažnai (80–99%) | 2 ligose |
| GTF2Igeneral transcription factor IIi | Labai dažnai (80–99%) | 1 ligoje |
| GTF2IRD1GTF2I repeat domain containing 1 | Labai dažnai (80–99%) | 1 ligoje |
| GTF2IRD2GTF2I repeat domain containing 2 | Labai dažnai (80–99%) | 1 ligoje |
| HMBShydroxymethylbilane synthase | Labai dažnai (80–99%) | 2 ligose |
| JAK2Janus kinase 2 | Labai dažnai (80–99%) | 2 ligose |
| KRASKRas proto-oncogene, GTPase | Labai dažnai (80–99%) | 2 ligose |
| LIG3DNA ligase 3 | Labai dažnai (80–99%) | 1 ligoje |
| LIMK1LIM domain kinase 1 | Labai dažnai (80–99%) | 1 ligoje |
| MEFVMEFV innate immunity regulator, pyrin | Labai dažnai (80–99%) | 4 ligose |
| METMET proto-oncogene, receptor tyrosine kinase | Labai dažnai (80–99%) | 1 ligoje |
| METTL27methyltransferase like 27 | Labai dažnai (80–99%) | 1 ligoje |
| MLH1mutL homolog 1 | Labai dažnai (80–99%) | 1 ligoje |
| MSH2mutS homolog 2 | Labai dažnai (80–99%) | 1 ligoje |
| MSH6mutS homolog 6 | Labai dažnai (80–99%) | 1 ligoje |
| MUTYHmutY DNA glycosylase | Labai dažnai (80–99%) | 1 ligoje |
| MVKmevalonate kinase | Labai dažnai (80–99%) | 2 ligose |
| NCF1neutrophil cytosolic factor 1 | Labai dažnai (80–99%) | 1 ligoje |
| NPATnuclear protein, coactivator of histone transcription | Labai dažnai (80–99%) | 1 ligoje |
| NRTNneurturin | Labai dažnai (80–99%) | 1 ligoje |
| PALB2partner and localizer of BRCA2 | Labai dažnai (80–99%) | 1 ligoje |
| PALLDpalladin, cytoskeletal associated protein | Labai dažnai (80–99%) | 1 ligoje |
| PIK3CAphosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha | Labai dažnai (80–99%) | 1 ligoje |
| PMS1PMS1 homolog 1, mismatch repair system component | Labai dažnai (80–99%) | 1 ligoje |
| PMS2PMS1 homolog 2, mismatch repair system component | Labai dažnai (80–99%) | 1 ligoje |
| POLD1DNA polymerase delta 1, catalytic subunit | Labai dažnai (80–99%) | 1 ligoje |
| POLEDNA polymerase epsilon, catalytic subunit | Labai dažnai (80–99%) | 1 ligoje |
| POLGDNA polymerase gamma, catalytic subunit | Labai dažnai (80–99%) | 3 ligose |
| PRSS1serine protease 1 | Labai dažnai (80–99%) | 2 ligose |
| PRSS2serine protease 2 | Labai dažnai (80–99%) | 2 ligose |
| RABL3RAB, member of RAS oncogene family like 3 | Labai dažnai (80–99%) | 1 ligoje |
| RETret proto-oncogene | Labai dažnai (80–99%) | 1 ligoje |
| RFC2replication factor C subunit 2 | Labai dažnai (80–99%) | 1 ligoje |
| RPS20ribosomal protein S20 | Labai dažnai (80–99%) | 1 ligoje |
| RRM2Bribonucleotide reductase regulatory TP53 inducible subunit M2B | Labai dažnai (80–99%) | 1 ligoje |
| SDHAsuccinate dehydrogenase complex flavoprotein subunit A | Labai dažnai (80–99%) | 2 ligose |
| SDHBsuccinate dehydrogenase complex iron sulfur subunit B | Labai dažnai (80–99%) | 2 ligose |
| SDHCsuccinate dehydrogenase complex subunit C | Labai dažnai (80–99%) | 2 ligose |
| SEMA3Csemaphorin 3C | Labai dažnai (80–99%) | 1 ligoje |
| SEMA3Dsemaphorin 3D | Labai dažnai (80–99%) | 1 ligoje |
| SEMA4Asemaphorin 4A | Labai dažnai (80–99%) | 1 ligoje |
| SERPING1serpin family G member 1 | Labai dažnai (80–99%) | 2 ligose |
| SIsucrase-isomaltase | Labai dažnai (80–99%) | 2 ligose |
| SMAD4SMAD family member 4 | Labai dažnai (80–99%) | 2 ligose |
| SMOsmoothened, frizzled class receptor | Labai dažnai (80–99%) | 1 ligoje |
| SOX10SRY-box transcription factor 10 | Labai dažnai (80–99%) | 2 ligose |
| SREBF1sterol regulatory element binding transcription factor 1 | Labai dažnai (80–99%) | 1 ligoje |
| STX1Asyntaxin 1A | Labai dažnai (80–99%) | 1 ligoje |
| TBL2transducin beta like 2 | Labai dažnai (80–99%) | 1 ligoje |
| TGFBR2transforming growth factor beta receptor 2 | Labai dažnai (80–99%) | 1 ligoje |
| TMEM270transmembrane protein 270 | Labai dažnai (80–99%) | 1 ligoje |
| TNFRSF1ATNF receptor superfamily member 1A | Labai dažnai (80–99%) | 2 ligose |
| TP53tumor protein p53 | Labai dažnai (80–99%) | 2 ligose |
| TRPV6transient receptor potential cation channel subfamily V member 6 | Labai dažnai (80–99%) | 1 ligoje |
| TYMPthymidine phosphorylase | Labai dažnai (80–99%) | 2 ligose |
| VPS37DVPS37D subunit of ESCRT-I | Labai dažnai (80–99%) | 1 ligoje |
| WT1WT1 transcription factor | Labai dažnai (80–99%) | 3 ligose |
| ABCA1ATP binding cassette subfamily A member 1 | Dažnai (30–79%) | 1 ligoje |
| ALADaminolevulinate dehydratase | Dažnai (30–79%) | 1 ligoje |
| APCAPC regulator of Wnt signaling pathway | Dažnai (30–79%) | 2 ligose |
| ASXL1ASXL transcriptional regulator 1 | Dažnai (30–79%) | 2 ligose |
| BMP6bone morphogenetic protein 6 | Dažnai (30–79%) | 1 ligoje |
| C4Acomplement C4A (Chido/Rodgers blood group) | Dažnai (30–79%) | 1 ligoje |
| CALRcalreticulin | Dažnai (30–79%) | 1 ligoje |
| CBLCbl proto-oncogene | Dažnai (30–79%) | 1 ligoje |
| CCR1C-C motif chemokine receptor 1 | Dažnai (30–79%) | 1 ligoje |
| CD55CD55 molecule (Cromer blood group) | Dažnai (30–79%) | 1 ligoje |
| CDKN1Bcyclin dependent kinase inhibitor 1B | Dažnai (30–79%) | 1 ligoje |
| CDKN2Bcyclin dependent kinase inhibitor 2B | Dažnai (30–79%) | 1 ligoje |
| CLCNKBchloride voltage-gated channel Kb | Dažnai (30–79%) | 1 ligoje |
| CLDN16claudin 16 | Dažnai (30–79%) | 1 ligoje |
| CLPBClpB family mitochondrial disaggregase | Dažnai (30–79%) | 1 ligoje |
| CNBPCCHC-type zinc finger nucleic acid binding protein | Dažnai (30–79%) | 1 ligoje |
| CTLA4cytotoxic T-lymphocyte associated protein 4 | Dažnai (30–79%) | 1 ligoje |
| CTR9CTR9 component of Paf1/RNA polymerase II complex | Dažnai (30–79%) | 1 ligoje |
| DIS3L2DIS3 like 3'-5' exoribonuclease 2 | Dažnai (30–79%) | 1 ligoje |
| DNASE1L3deoxyribonuclease 1L3 | Dažnai (30–79%) | 1 ligoje |
| ELANEelastase, neutrophil expressed | Dažnai (30–79%) | 2 ligose |
| ELF4E74 like ETS transcription factor 4 | Dažnai (30–79%) | 1 ligoje |
| EPORerythropoietin receptor | Dažnai (30–79%) | 1 ligoje |
| ERAP1endoplasmic reticulum aminopeptidase 1 | Dažnai (30–79%) | 1 ligoje |
| F5coagulation factor V | Dažnai (30–79%) | 1 ligoje |
| FASFas cell surface death receptor | Dažnai (30–79%) | 1 ligoje |
| GBA1glucosylceramidase beta 1 | Dažnai (30–79%) | 1 ligoje |
| GCGRglucagon receptor | Dažnai (30–79%) | 2 ligose |
| GFI1growth factor independent 1 transcriptional repressor | Dažnai (30–79%) | 1 ligoje |
| GNA11G protein subunit alpha 11 | Dažnai (30–79%) | 1 ligoje |
| GOSR2golgi SNAP receptor complex member 2 | Dažnai (30–79%) | 1 ligoje |
| GPC3glypican 3 | Dažnai (30–79%) | 1 ligoje |
| H19H19 imprinted maternally expressed transcript | Dažnai (30–79%) | 1 ligoje |
| HFEhomeostatic iron regulator | Dažnai (30–79%) | 2 ligose |
| HLA-Bmajor histocompatibility complex, class I, B | Dažnai (30–79%) | 4 ligose |
| HLA-DPA1major histocompatibility complex, class II, DP alpha 1 | Dažnai (30–79%) | 1 ligoje |
| HLA-DPB1major histocompatibility complex, class II, DP beta 1 | Dažnai (30–79%) | 1 ligoje |
| IFNGR1interferon gamma receptor 1 | Dažnai (30–79%) | 1 ligoje |
| IL10interleukin 10 | Dažnai (30–79%) | 1 ligoje |
| IL12Ainterleukin 12A | Dažnai (30–79%) | 1 ligoje |
| IL12A-AS1IL12A antisense RNA 1 | Dažnai (30–79%) | 1 ligoje |
| IL23Rinterleukin 23 receptor | Dažnai (30–79%) | 1 ligoje |
| KLRC4killer cell lectin like receptor C4 | Dažnai (30–79%) | 1 ligoje |
| MED12mediator complex subunit 12 | Dažnai (30–79%) | 1 ligoje |
| MEN1menin 1 | Dažnai (30–79%) | 1 ligoje |
| MITFmelanocyte inducing transcription factor | Dažnai (30–79%) | 1 ligoje |
| NKX2-5NK2 homeobox 5 | Dažnai (30–79%) | 1 ligoje |
| NLRP3NLR family pyrin domain containing 3 | Dažnai (30–79%) | 2 ligose |
| NOD2nucleotide binding oligomerization domain containing 2 | Dažnai (30–79%) | 2 ligose |
| OTULINOTU deubiquitinase with linear linkage specificity | Dažnai (30–79%) | 1 ligoje |
| PKHD1PKHD1 ciliary IPT domain containing fibrocystin/polyductin | Dažnai (30–79%) | 1 ligoje |
| POU6F2POU class 6 homeobox 2 | Dažnai (30–79%) | 1 ligoje |
| PRKAR1Aprotein kinase cAMP-dependent type I regulatory subunit alpha | Dažnai (30–79%) | 2 ligose |
| PRTN3proteinase 3 | Dažnai (30–79%) | 1 ligoje |
| PTENphosphatase and tensin homolog | Dažnai (30–79%) | 1 ligoje |
| PTPN22protein tyrosine phosphatase non-receptor type 22 | Dažnai (30–79%) | 2 ligose |
| RBCK1RANBP2-type and C3HC4-type zinc finger containing 1 | Dažnai (30–79%) | 1 ligoje |
| RESTRE1 silencing transcription factor | Dažnai (30–79%) | 1 ligoje |
| RIPK1receptor interacting serine/threonine kinase 1 | Dažnai (30–79%) | 1 ligoje |
| RUNX1RUNX family transcription factor 1 | Dažnai (30–79%) | 1 ligoje |
| SAA1serum amyloid A1 | Dažnai (30–79%) | 1 ligoje |
| SCARB2scavenger receptor class B member 2 | Dažnai (30–79%) | 1 ligoje |
| SCN1Bsodium voltage-gated channel beta subunit 1 | Dažnai (30–79%) | 1 ligoje |
| SCN5Asodium voltage-gated channel alpha subunit 5 | Dažnai (30–79%) | 1 ligoje |
| SDHDsuccinate dehydrogenase complex subunit D | Dažnai (30–79%) | 1 ligoje |
| SLC12A3solute carrier family 12 member 3 | Dažnai (30–79%) | 2 ligose |
| SRP19signal recognition particle 19 | Dažnai (30–79%) | 1 ligoje |
| SRSF2serine and arginine rich splicing factor 2 | Dažnai (30–79%) | 2 ligose |
| STAT4signal transducer and activator of transcription 4 | Dažnai (30–79%) | 2 ligose |
| TCIRG1T cell immune regulator 1, ATPase H+ transporting V0 subunit a3 | Dažnai (30–79%) | 1 ligoje |
| TERTtelomerase reverse transcriptase | Dažnai (30–79%) | 1 ligoje |
| TET2tet methylcytosine dioxygenase 2 | Dažnai (30–79%) | 2 ligose |
| TLR4toll like receptor 4 | Dažnai (30–79%) | 1 ligoje |
| TRIM28tripartite motif containing 28 | Dažnai (30–79%) | 1 ligoje |
| TRIP13thyroid hormone receptor interactor 13 | Dažnai (30–79%) | 1 ligoje |
| TRPM4transient receptor potential cation channel subfamily M member 4 | Dažnai (30–79%) | 1 ligoje |
| TSC1TSC complex subunit 1 | Dažnai (30–79%) | 1 ligoje |
| TSC2TSC complex subunit 2 | Dažnai (30–79%) | 1 ligoje |
| UBAC2UBA domain containing 2 | Dažnai (30–79%) | 1 ligoje |
| UQCRHubiquinol-cytochrome c reductase hinge protein | Dažnai (30–79%) | 1 ligoje |
| ZNRF3zinc and ring finger 3 | Dažnai (30–79%) | 1 ligoje |
| ABCC2ATP binding cassette subfamily C member 2 | Kartais (5–29%) | 1 ligoje |
| ACTN4actinin alpha 4 | Kartais (5–29%) | 1 ligoje |
| ALDH4A1aldehyde dehydrogenase 4 family member A1 | Kartais (5–29%) | 1 ligoje |
| ALG8ALG8 alpha-1,3-glucosyltransferase | Kartais (5–29%) | 1 ligoje |
| ANK1ankyrin 1 | Kartais (5–29%) | 1 ligoje |
| ANKFY1ankyrin repeat and FYVE domain containing 1 | Kartais (5–29%) | 1 ligoje |
| ANLNanillin, actin binding protein | Kartais (5–29%) | 1 ligoje |
| APOL1apolipoprotein L1 | Kartais (5–29%) | 1 ligoje |
| ARHGAP24Rho GTPase activating protein 24 | Kartais (5–29%) | 1 ligoje |
| ARHGDIARho GDP dissociation inhibitor alpha | Kartais (5–29%) | 1 ligoje |
| ATP7BATPase copper transporting beta | Kartais (5–29%) | 1 ligoje |
| AVILadvillin | Kartais (5–29%) | 1 ligoje |
| BCL10BCL10 immune signaling adaptor | Kartais (5–29%) | 1 ligoje |
| BCL11ABCL11 transcription factor A | Kartais (5–29%) | 1 ligoje |
| BCORBCL6 corepressor | Kartais (5–29%) | 1 ligoje |
| BIRC3baculoviral IAP repeat containing 3 | Kartais (5–29%) | 1 ligoje |
| BNC2basonuclin zinc finger protein 2 | Kartais (5–29%) | 1 ligoje |
| CCND1cyclin D1 | Kartais (5–29%) | 1 ligoje |
| CD2APCD2 associated protein | Kartais (5–29%) | 1 ligoje |
| CD46CD46 molecule | Kartais (5–29%) | 1 ligoje |
| CFHcomplement factor H | Kartais (5–29%) | 1 ligoje |
| CFIcomplement factor I | Kartais (5–29%) | 1 ligoje |
| COL4A3collagen type IV alpha 3 chain | Kartais (5–29%) | 1 ligoje |
| COQ8Bcoenzyme Q8B | Kartais (5–29%) | 1 ligoje |
| CORINcorin, serine peptidase | Kartais (5–29%) | 1 ligoje |
| CRB2crumbs cell polarity complex component 2 | Kartais (5–29%) | 1 ligoje |
| DAAM2dishevelled associated activator of morphogenesis 2 | Kartais (5–29%) | 1 ligoje |
| DDIT3DNA damage inducible transcript 3 | Kartais (5–29%) | 1 ligoje |
| DMPKDM1 protein kinase | Kartais (5–29%) | 1 ligoje |
| EMP2epithelial membrane protein 2 | Kartais (5–29%) | 1 ligoje |
| EPB42erythrocyte membrane protein band 4.2 | Kartais (5–29%) | 1 ligoje |
| FGF13fibroblast growth factor 13 | Kartais (5–29%) | 1 ligoje |
| FIP1L1factor interacting with PAPOLA and CPSF1 | Kartais (5–29%) | 1 ligoje |
| FLT1fms related receptor tyrosine kinase 1 | Kartais (5–29%) | 1 ligoje |
| FOXP1forkhead box P1 | Kartais (5–29%) | 1 ligoje |
| FUSFUS RNA binding protein | Kartais (5–29%) | 1 ligoje |
| GAPVD1GTPase activating protein and VPS9 domains 1 | Kartais (5–29%) | 1 ligoje |
| GPR35G protein-coupled receptor 35 | Kartais (5–29%) | 1 ligoje |
| HBBhemoglobin subunit beta | Kartais (5–29%) | 3 ligose |
| HBG1hemoglobin subunit gamma 1 | Kartais (5–29%) | 1 ligoje |
| HBG2hemoglobin subunit gamma 2 | Kartais (5–29%) | 1 ligoje |
| HELLPARHELLP associated long non-coding RNA | Kartais (5–29%) | 1 ligoje |
| HIVEP2HIVEP zinc finger 2 | Kartais (5–29%) | 1 ligoje |
| HLA-DRB1major histocompatibility complex, class II, DR beta 1 | Kartais (5–29%) | 2 ligose |
| IGHimmunoglobulin heavy locus | Kartais (5–29%) | 1 ligoje |
| IKZF1IKAROS family zinc finger 1 | Kartais (5–29%) | 1 ligoje |
| IL6interleukin 6 | Kartais (5–29%) | 2 ligose |
| INF2inverted formin 2 | Kartais (5–29%) | 1 ligoje |
| IRAK1interleukin 1 receptor associated kinase 1 | Kartais (5–29%) | 1 ligoje |
| IRF2BP2interferon regulatory factor 2 binding protein 2 | Kartais (5–29%) | 1 ligoje |
| KANK2KN motif and ankyrin repeat domains 2 | Kartais (5–29%) | 1 ligoje |
| KCNN4potassium calcium-activated channel subfamily N member 4 | Kartais (5–29%) | 1 ligoje |
| KITKIT proto-oncogene, receptor tyrosine kinase | Kartais (5–29%) | 2 ligose |
| KLF1KLF transcription factor 1 | Kartais (5–29%) | 1 ligoje |
| LACC1laccase domain multifunctional purine nucleosidase 1 | Kartais (5–29%) | 1 ligoje |
| LAMA5laminin subunit alpha 5 | Kartais (5–29%) | 1 ligoje |
| LRP5LDL receptor related protein 5 | Kartais (5–29%) | 1 ligoje |
| MAGI2membrane associated guanylate kinase, WW and PDZ domain containing 2 | Kartais (5–29%) | 1 ligoje |
| MALT1MALT1 paracaspase | Kartais (5–29%) | 1 ligoje |
| MIFmacrophage migration inhibitory factor | Kartais (5–29%) | 1 ligoje |
| MMUTmethylmalonyl-CoA mutase | Kartais (5–29%) | 1 ligoje |
| MST1macrophage stimulating 1 | Kartais (5–29%) | 1 ligoje |
| MYCMYC proto-oncogene, bHLH transcription factor | Kartais (5–29%) | 1 ligoje |
| MYO1Emyosin IE | Kartais (5–29%) | 1 ligoje |
| NABP1nucleic acid binding protein 1 | Kartais (5–29%) | 1 ligoje |
| NPHS1NPHS1 adhesion molecule, nephrin | Kartais (5–29%) | 1 ligoje |
| NPHS2NPHS2 stomatin family member, podocin | Kartais (5–29%) | 1 ligoje |
| NPM1nucleophosmin 1 | Kartais (5–29%) | 1 ligoje |
| NUMA1nuclear mitotic apparatus protein 1 | Kartais (5–29%) | 1 ligoje |
| NUP107nucleoporin 107 | Kartais (5–29%) | 1 ligoje |
| NUP133nucleoporin 133 | Kartais (5–29%) | 1 ligoje |
| NUP160nucleoporin 160 | Kartais (5–29%) | 1 ligoje |
| NUP205nucleoporin 205 | Kartais (5–29%) | 1 ligoje |
| NUP37nucleoporin 37 | Kartais (5–29%) | 1 ligoje |
| NUP85nucleoporin 85 | Kartais (5–29%) | 1 ligoje |
| NUP93nucleoporin 93 | Kartais (5–29%) | 1 ligoje |
| OTCornithine transcarbamylase | Kartais (5–29%) | 1 ligoje |
| P4HA2prolyl 4-hydroxylase subunit alpha 2 | Kartais (5–29%) | 1 ligoje |
| PAX2paired box 2 | Kartais (5–29%) | 1 ligoje |
| PIEZO1piezo type mechanosensitive ion channel component 1 (Er blood group) | Kartais (5–29%) | 1 ligoje |
| PLCE1phospholipase C epsilon 1 | Kartais (5–29%) | 1 ligoje |
| PMLPML nuclear body scaffold | Kartais (5–29%) | 1 ligoje |
| POMT1protein O-mannosyltransferase 1 | Kartais (5–29%) | 1 ligoje |
| PORCNporcupine O-acyltransferase | Kartais (5–29%) | 1 ligoje |
| PRKCSHPRKCSH beta subunit of glucosidase II | Kartais (5–29%) | 1 ligoje |
| PTPN3protein tyrosine phosphatase non-receptor type 3 | Kartais (5–29%) | 1 ligoje |
| PTPROprotein tyrosine phosphatase receptor type O | Kartais (5–29%) | 1 ligoje |
| RARAretinoic acid receptor alpha | Kartais (5–29%) | 1 ligoje |
| RNF168ring finger protein 168 | Kartais (5–29%) | 1 ligoje |
| ROS1ROS proto-oncogene 1, receptor tyrosine kinase | Kartais (5–29%) | 1 ligoje |
| SAT1spermidine/spermine N1-acetyltransferase 1 | Kartais (5–29%) | 1 ligoje |
| SEC63SEC63 protein translocation regulator | Kartais (5–29%) | 1 ligoje |
| SEMA4Dsemaphorin 4D | Kartais (5–29%) | 1 ligoje |
| SLC4A1solute carrier family 4 member 1 (Diego blood group) | Kartais (5–29%) | 2 ligose |
| SMPD1sphingomyelin phosphodiesterase 1 | Kartais (5–29%) | 1 ligoje |
| SPP1secreted phosphoprotein 1 | Kartais (5–29%) | 1 ligoje |
| SPTA1spectrin alpha, erythrocytic 1 | Kartais (5–29%) | 2 ligose |
| SPTBspectrin beta, erythrocytic | Kartais (5–29%) | 2 ligose |
| STAT3signal transducer and activator of transcription 3 | Kartais (5–29%) | 2 ligose |
| STAT5Bsignal transducer and activator of transcription 5B | Kartais (5–29%) | 1 ligoje |
| STOX1storkhead box 1 | Kartais (5–29%) | 1 ligoje |
| SYKspleen associated tyrosine kinase | Kartais (5–29%) | 1 ligoje |
| TBC1D8BTBC1 domain family member 8B | Kartais (5–29%) | 1 ligoje |
| TBK1TANK binding kinase 1 | Kartais (5–29%) | 1 ligoje |
| TBL1XR1TBL1X/Y related 1 | Kartais (5–29%) | 1 ligoje |
| TCF4transcription factor 4 | Kartais (5–29%) | 1 ligoje |
| TFR2transferrin receptor 2 | Kartais (5–29%) | 1 ligoje |
| TREHtrehalase | Kartais (5–29%) | 2 ligose |
| TRPC6transient receptor potential cation channel subfamily C member 6 | Kartais (5–29%) | 1 ligoje |
| UNC45Aunc-45 myosin chaperone A | Kartais (5–29%) | 1 ligoje |
| VHLvon Hippel-Lindau tumor suppressor | Kartais (5–29%) | 1 ligoje |
| ZBTB16zinc finger and BTB domain containing 16 | Kartais (5–29%) | 1 ligoje |
| ABCB11ATP binding cassette subfamily B member 11 | Retai (1–4 %) | 1 ligoje |
| ABCB4ATP binding cassette subfamily B member 4 | Retai (1–4 %) | 1 ligoje |
| ATP8B1ATPase phospholipid transporting 8B1 | Retai (1–4 %) | 1 ligoje |
| EPB41erythrocyte membrane protein band 4.1 | Retai (1–4 %) | 1 ligoje |
| GYPCglycophorin C (Gerbich blood group) | Retai (1–4 %) | 1 ligoje |
| NR1H4nuclear receptor subfamily 1 group H member 4 | Retai (1–4 %) | 1 ligoje |
| SPTBN1spectrin beta, non-erythrocytic 1 | Retai (1–4 %) | 1 ligoje |
| ABCG8ATP binding cassette subfamily G member 8 | Neužfiksuota | 1 ligoje |
| ACTG2actin gamma 2, smooth muscle | Neužfiksuota | 1 ligoje |
| ADA2adenosine deaminase 2 | Neužfiksuota | 1 ligoje |
| BMP2bone morphogenetic protein 2 | Neužfiksuota | 1 ligoje |
| CELcarboxyl ester lipase | Neužfiksuota | 1 ligoje |
| CFTRCF transmembrane conductance regulator | Neužfiksuota | 1 ligoje |
| GUCY2Cguanylate cyclase 2C | Neužfiksuota | 1 ligoje |
| HLA-DQA1major histocompatibility complex, class II, DQ alpha 1 | Neužfiksuota | 1 ligoje |
| HLA-DQB1major histocompatibility complex, class II, DQ beta 1 | Neužfiksuota | 1 ligoje |
| HPS1HPS1 biogenesis of lysosomal organelles complex 3 subunit 1 | Neužfiksuota | 1 ligoje |
| HS3ST6heparan sulfate-glucosamine 3-sulfotransferase 6 | Neužfiksuota | 1 ligoje |
| KIF1Bkinesin family member 1B | Neužfiksuota | 1 ligoje |
| MCM6minichromosome maintenance complex component 6 | Neužfiksuota | 1 ligoje |
| MLYCDmalonyl-CoA decarboxylase | Neužfiksuota | 1 ligoje |
| NLRP12NLR family pyrin domain containing 12 | Neužfiksuota | 1 ligoje |
| OPLAH5-oxoprolinase, ATP-hydrolysing | Neužfiksuota | 1 ligoje |
| SLC25A26solute carrier family 25 member 26 | Neužfiksuota | 1 ligoje |
| SPINK1serine peptidase inhibitor Kazal type 1 | Neužfiksuota | 2 ligose |
Kaip dažnai šis požymis pasitaiko žmonėms, turintiems vieną iš geno sukeliamų ligų, ir kuris dažnis tarp jų didžiausias, pagal Žmogaus fenotipo ontologijos duomenis. Šiuose puslapiuose aprašomi požymiai ir juos grindžiantys tyrimai; tai nėra diagnozė, o su simptomais kreipkitės į gydytoją ar genetikos konsultantą.
Siauresni požymiai
Platesni požymiai
Iš kur tai žinoma
- Žmogaus fenotipo ontologija, 2026-09-01 leidimas: požymis, jo pavadinimai, apibrėžimas ir su juo susiję genai. Daugiau sužinokite svetainėje hpo.jax.org.
- Duomenų leidimas 2026.10.16-c6eea6bf.
Kam padedameMūsų mokslasProduktaiRezultatai
PrisijungtiKlaustiPradėtinuo 449 $
Vienas testas. Atsakymai visam gyvenimui.
Nuo 449 $Nemokamas pristatymas · Rezultatai per 6–8 savaites